chr2-70978793-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001115116.2(ANKRD53):c.148G>A(p.Asp50Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,571,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001115116.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ANKRD53 | NM_001115116.2 | c.148G>A | p.Asp50Asn | missense_variant | 1/6 | ENST00000360589.4 | |
LOC105374795 | XR_001739534.2 | n.440-2485C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ANKRD53 | ENST00000360589.4 | c.148G>A | p.Asp50Asn | missense_variant | 1/6 | 2 | NM_001115116.2 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000708 AC: 13AN: 183654Hom.: 0 AF XY: 0.000122 AC XY: 12AN XY: 98296
GnomAD4 exome AF: 0.0000240 AC: 34AN: 1418850Hom.: 0 Cov.: 30 AF XY: 0.0000356 AC XY: 25AN XY: 701818
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74488
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2022 | The c.148G>A (p.D50N) alteration is located in exon 1 (coding exon 1) of the ANKRD53 gene. This alteration results from a G to A substitution at nucleotide position 148, causing the aspartic acid (D) at amino acid position 50 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at